Opportunity Overview
The Cancer Prevention and Research Institute of Texas (CPRIT) lists the Core Facility Support Award, FY 2027 Cycle 2, as an open Academic Research funding opportunity. The award supports development or improvement of shared core facilities that provide valuable research services and capabilities to scientifically meritorious cancer-research projects in Texas.
Funding and Application Window
CPRIT provides up to $2 million over five years. The FY 2027 Cycle 2 application window opens September 16, 2026 and closes November 18, 2026. CPRIT directs FY27 Cycle 2 Academic Research applicants to use its new Grant Management Platform when the application window opens.
Core Facility Strategy
The strongest proposals will show that the requested investment creates or materially improves a shared research capability that is difficult for individual investigators to build alone. CPRIT states that it will look with special favor on facilities designed to serve cancer researchers at multiple Texas research institutions, particularly TREC-eligible institutions.
Eligible Institutional Model
The facility must directly support cancer research in Texas and be led by a qualified facility-director principal investigator under the RFA’s institutional, appointment, residency and effort requirements. Applicants should identify a credible Texas-based investigator user group and demonstrate that the proposed core will expand research capacity rather than simply replace routine institutional support. CPRIT generally limits institutions to one application under this mechanism, subject to the specific exceptions stated in the controlling RFA.
Potential Uses of Award Funds
The RFA can support major shared-research needs such as scientific instruments and related installation, limited facility modifications required to place or operate approved equipment, maintenance and service contracts, core-facility leadership and technical personnel, and other research-use costs permitted by CPRIT. Every cost must be justified as necessary to create, expand or improve the shared cancer-research capability.
Atlas Analysis
Atlas Opportunity Score: 94/100. This is a high-value research-infrastructure mechanism because a single award can support up to five years of shared capability and can benefit investigators beyond one laboratory or department. Multi-institution reach, distinctive technical capability, demonstrated demand and a durable sustainability plan should materially strengthen competitiveness.
N9+ Direct Vendor Fit: conditional. This is not a general telehealth or clinical-equipment grant. Connected examination technology would only be defensible if it is genuinely part of a shared cancer-research core or protocol-facing research capability, the user base and scientific aims justify it, and CPRIT confirms that the proposed equipment and associated costs are allowable. Atlas should not position N9+ as a default core-facility purchase.
Next Action
Identify the proposed shared facility and user community, resolve the institutional application-limit process, confirm PI and organizational eligibility, define the scientific capability gap, obtain equipment and service-cost documentation, quantify demand across Texas cancer investigators, build the five-year operations and sustainability model, activate the CPRIT Grant Management Platform account, and prepare for the September 16 opening and November 18, 2026 deadline.
Verified source: Cancer Prevention and Research Institute of Texas, FY 2027 Cycle 2 Funding Opportunities and Core Facility Support Award RFA.